Pharmacist initiated intervention trial in osteoarthritis (PhIT-OA): A multidisciplinary intervention for knee osteoarthritis.

Scientist, Centre for Health Evaluation and Outcome Sciences, Providence Health Care Research Institute, Vancouver BC. .
Arthritis care & research 12/2012; 64(12). DOI: 10.1002/acr.21763
Source: PubMed

ABSTRACT BACKGROUND: Knee osteoarthritis (OA) is a commonly undiagnosed condition and care is often not provided. Pharmacists are uniquely placed for launching a multidisciplinary intervention for knee OA. METHODS: A cluster, randomized, controlled trial with pharmacies providing either the intervention or usual care (14 and 18 pharmacies, respectively). The intervention included a validated knee OA screening questionnaire, education, pain medication management, physiotherapy guided exercise and communication with the primary care physician. Usual care consisted of an educational pamphlet. OUTCOMES: The primary outcome was the pass rate on the Arthritis Foundation's quality indicators for OA. Secondary outcomes included the WOMAC, the Lower Extremity Function Scale (LEFS), Paper Adaptive Test-5D (PAT-5D) and Health Utilities Index Mark 3 (HUI3). RESULTS: 139 patients were assigned to the control (n=66) and intervention (n=73). There were no differences between groups in baseline measures. The overall quality indicator pass rate, was significantly higher in the intervention compared to the control arm (difference of 45.2%, 95% CI (34.5, 55.9). Significant improvements were observed for the intervention care group as compared to the usual care in the WOMAC global, pain and function scores at 3 and 6 months (all p<0.01), PAT-5D daily activity scores at three and six months (both p<0.05), PAT-5D pain scores at 6 months (p,0.05), HUI3 single-attribute pain score at 3 and 6 months, (all p<0.05) and the LEFS scores at 6 months (p<0.05). CONCLUSIONS: Pharmacists can launch a multidisciplinary intervention to identify knee OA cases, improve the utilization of treatments, and improve function, pain and QoL. © 2012 by the American College of Rheumatology.

Download full-text


Available from: Maja Grubisic, Jun 18, 2015
  • Source
    Cochrane database of systematic reviews (Online) 01/2015; 1:CD004376. DOI:10.1002/14651858.CD004376.pub3 · 5.94 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: With musculoskeletal conditions now identified as the second highest cause of the morbidity-related global burden of disease, models of care for the prevention and management of disability related to musculoskeletal conditions are an imperative. Musculoskeletal models of care aim to describe how to operationalise evidence-based guidelines for musculoskeletal conditions and thus support implementation by clinical teams and their health systems. This review of models of care for musculoskeletal pain conditions, osteoarthritis, rheumatoid arthritis, osteoporosis and musculoskeletal injuries and trauma outlines health system and local implementation strategies to improve consumer outcomes, including supporting access to multidisciplinary teams, improving access for vulnerable populations and levering digital technologies to support access and self-management. However, the challenge remains of how to inform health system decision-makers and policy about the human and fiscal benefits for broad implementation across health services. Recommendations are made for potential solutions, as well as highlighting where further evidence is required.
    Bailli&egrave re s Best Practice and Research in Clinical Rheumatology 08/2014; 28(3). DOI:10.1016/j.berh.2014.07.001 · 3.06 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Adaptive tests are increasingly being used to assess health-related quality of life in patients with a variety of medical conditions, including osteoarthritis (OA) of the knee. This approach has recently been used to assess health state utility valuations (HSUV) for use in quality-adjusted life-year calculations. To accurately assess incremental value for money, these tools must be responsive. Therefore, we examined the responsiveness of the Health Utilities Index mark 3 (HUI3) and Paper Adaptive Test-5D (PAT-5DQOL) in a group of patients with knee OA. We used patient-level data from a randomized controlled trial evaluating a pharmacist-initiated multidisciplinary intervention in newly diagnosed patients with knee OA. The mean change for utility scores from baseline to 6 months was calculated, as well as effect size (ES) and standardized response mean (SRM) for the HUI3 and PAT-5DQOL, and generalized additive model plots, using the Western Ontario and McMaster Osteoarthritis index as a reference standard. When patients were assessed based on whether their condition had improved, remained unchanged, or worsened over time, the PAT-5DQOL showed greater responsiveness in patients whose condition had either improved or worsened. ES and SRM were generally small for both instruments. The PAT-5DQOL is more responsive to change over time than the HUI3 in patients with knee OA.
    The Journal of Rheumatology 11/2013; 40(12). DOI:10.3899/jrheum.130176 · 3.17 Impact Factor